[HTML][HTML] Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans

LM Holdt, A Stahringer, K Sass, G Pichler… - Nature …, 2016 - nature.com
LM Holdt, A Stahringer, K Sass, G Pichler, NA Kulak, W Wilfert, A Kohlmaier, A Herbst…
Nature communications, 2016nature.com
Circular RNAs (circRNAs) are broadly expressed in eukaryotic cells, but their molecular
mechanism in human disease remains obscure. Here we show that circular antisense non-
coding RNA in the INK4 locus (circANRIL), which is transcribed at a locus of atherosclerotic
cardiovascular disease on chromosome 9p21, confers atheroprotection by controlling
ribosomal RNA (rRNA) maturation and modulating pathways of atherogenesis. CircANRIL
binds to pescadillo homologue 1 (PES1), an essential 60S-preribosomal assembly factor …
Abstract
Circular RNAs (circRNAs) are broadly expressed in eukaryotic cells, but their molecular mechanism in human disease remains obscure. Here we show that circular antisense non-coding RNA in the INK4 locus (circANRIL), which is transcribed at a locus of atherosclerotic cardiovascular disease on chromosome 9p21, confers atheroprotection by controlling ribosomal RNA (rRNA) maturation and modulating pathways of atherogenesis. CircANRIL binds to pescadillo homologue 1 (PES1), an essential 60S-preribosomal assembly factor, thereby impairing exonuclease-mediated pre-rRNA processing and ribosome biogenesis in vascular smooth muscle cells and macrophages. As a consequence, circANRIL induces nucleolar stress and p53 activation, resulting in the induction of apoptosis and inhibition of proliferation, which are key cell functions in atherosclerosis. Collectively, these findings identify circANRIL as a prototype of a circRNA regulating ribosome biogenesis and conferring atheroprotection, thereby showing that circularization of long non-coding RNAs may alter RNA function and protect from human disease.
nature.com